Fresenius Medical Care AG
FMS· NYSE
FMSFresenius Medical Care AG
Source filing unavailable
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | €4.77B | €4.83B | €4.76B | €4.32B |
| Net Income | €187.03M | €140.36M | €147.14M | €218.58M |
| EPS Diluted | €0.64 | €0.48 | €0.50 | €0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR
